Tychon Bioscience discovers and develops prosthetic antigen receptors for oncolytic immunotherapy.
Business Model:
Revenue: $0
Employees: 11-50
Address: 227 Colfax Ave N Ste 148
City: Minneapolis
State: MN
Zip: 55405
Country: US
Tychon Bioscience discovers and develops prosthetic antigen receptors for oncolytic immunotherapy.
Contact Phone:
+16122001039
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2018 | Debt Financing | $200k | 11/2015 | Seed Round | $470k | 11/2015 | Equity | $470.7k | 12/2019 | Angel Round | $950k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|